A randomized Phase I/II study to evaluate safety and reactogenicity of a heat-stable rotavirus vaccine in healthy adults followed by evaluation of the safety, reactogenicity, and immunogenicity in infants

Objectives: To assess the safety and reactogenicity of single oral dose of heat-stable rotavirus vaccine (HSRV) in healthy adults aged 18–45 years followed by assessment of safety, reactogenicity, and immunogenicity of three doses of HSRV in healthy infants aged 6–8 weeks at enrollment. Trial Design...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Hum Vaccin Immunother
Hlavní autoři: Kanchan, Vibhu, Zaman, Khalequ, Aziz, Asma Binte, Zaman, Sheikh Farzana, Zaman, Farzana, Haque, Warda, Khanam, Mahbuba, Karim, Mohammad Mahbubul, Kale, Sachin, Ali, Syed Khalid, Goveia, Michelle G., Kaplan, Susan S., Gill, Davinder, Khan, Wasif Ali, Yunus, Mohammad, Singh, Ajitpal, Clemens, John D.
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2019
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7227685/
https://ncbi.nlm.nih.gov/pubmed/31526218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1664239
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky